Mon 03/29/2021 06:47 AM
Muted interest from financial sponsors for the sale of Fullerton Healthcare Corporation Ltd. (FHCL) may have stalled the sale process run by sellside adviser BofA Securities, according to two sources with knowledge. The sale process follows an earlier attempt to exit parts of the business through a special purpose acquisition company (SPAC), backed by FHCL’s original private equity sponsor, SIN Capital, according to the same sources.
First round bids were due March 16, said one of
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2021 Reorg Research, Inc. All rights reserved.